GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 399 filers reported holding GUARDANT HEALTH INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $48,000 | -85.6% | 1,200 | -64.1% | 0.01% | -83.8% |
| Q4 2021 | $334,000 | -49.8% | 3,339 | -37.2% | 0.04% | -53.8% |
| Q3 2021 | $665,000 | -15.0% | 5,319 | -15.5% | 0.08% | -14.9% |
| Q2 2021 | $782,000 | -22.9% | 6,293 | -5.3% | 0.09% | -29.9% |
| Q1 2021 | $1,014,000 | -1.9% | 6,642 | -17.2% | 0.13% | -7.6% |
| Q4 2020 | $1,034,000 | -9.1% | 8,020 | -21.2% | 0.14% | -20.3% |
| Q3 2020 | $1,138,000 | -6.0% | 10,184 | -31.7% | 0.18% | -12.9% |
| Q2 2020 | $1,210,000 | +5.0% | 14,911 | -9.9% | 0.21% | -15.7% |
| Q1 2020 | $1,152,000 | +39.5% | 16,554 | +56.7% | 0.25% | +79.7% |
| Q4 2019 | $826,000 | +30.9% | 10,567 | +6.8% | 0.14% | +16.9% |
| Q3 2019 | $631,000 | -24.4% | 9,892 | +2.3% | 0.12% | -30.6% |
| Q2 2019 | $835,000 | +89.8% | 9,672 | +68.5% | 0.17% | +126.7% |
| Q1 2019 | $440,000 | +1417.2% | 5,740 | +640.6% | 0.08% | +1150.0% |
| Q4 2018 | $29,000 | – | 775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |